Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

Clinical trial NCT03374540 · COMPLETED

Trial details

NCT number: NCT03374540
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Nonvalvular Atrial Fibrillation

Start date: 2017-12-01
Primary completion: 2019-08-30
Enrollment: 78517

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.